This review describes the pathogenesis and significance of chemically-induced hepatocellular altered foci in rat liver. The measurement of induction of foci can be used for carcinogen detection and the measurement of the modulation of foci by chemicals other than the inducing agent identifies enhancers or inhibitors of liver carcinogenesis.
AstromADepierreJWErikssonL (1983). Characterization of drug-metabolizing systems in hyperplastic nodules from the livers of rats receiving 2-acetylaminofluorene in their diet. Carcinogenesis4: 577–581.
2.
BannaschP (1968). In: Recent Results in Cancer Research: The Cytoplasm of Hepatocytes During Carcinogenesis. Springer-Verlag, Inc., NY.
3.
BarbasonAHBetzEH (1981). Proliferation of preneoplastic lesions after discontinuation of chronic DEN feeding in the development of hepatomas in rat. Br. J. Cancer44: 561–566.
4.
BerenblumI (1974). In: Carcinogenesis as a Biological Problem. North Holland/American Elsevier, Amsterdam, pp. 43–49.
5.
BoltHMLaibRJStockleG (1979). Formation of preneoplastic hepatocellular foci by vinyl bromide in newborn rats. Arch. Toxicol.43: 83–84.
6.
BurschWLauerBTimmermann-TrosienerIBarthelGSchupplerJSchulte-HermannR (1984). Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis5: 453–458.
7.
CameronRGImaidaKTsudaHItoI (1982). Promotive effects of steroids and bile acids on hepa-tocarcinogenesis initiated by diethylnitrosamine. Cancer Res.42: 2426–2428.
8.
ColumbanoALeddaGMRaoPMRajalakshmiSSarmaDSR (1982). Dietary orotic acid, a new selective growth stimulus for carcinogen altered hepatocytes in rat. Cancer Lett.16: 191–196.
9.
CouriDWiltSRMilksMM (1982). Methapyrilene effects on initiation and promotion of gamma-glutamyl-transpeptidase positive foci in rat liver. Res. Commun. Chem. Pathol. Pharmacol.35: 51–61.
10.
DeangeloABGarrettCT (1983). Inhibition of development of preneoplastic lesions in the livers of rats fed a weekly carcinogenic environmental contaminant. Cancer Lett.20: 199–205.
11.
DemlEOesterleD (1982). Sex-dependent promoting effect of polychlorinated biphenyls on enzyme-altered islands induced by diethylnitrosamine in rat liver. Carcinogenesis3: 1449–1453.
12.
EmmelotPSchererE (1980). The first relevant cell stage in rat liver carcinogenesis. A quantitative approach. Biochim. Biophys. Acta605: 247–304.
13.
FarberE (1956). Similarities in the sequence of early histologic changes induced in the liver of the rat by ethionine, 2-acetylaminofluorene, and 3î-methyl-4-dimethylaminoazobenzene. Cancer Res.16: 142–148.
14.
FarberEParkerSGruensteinM (1979). The resistance of putative premalignant liver cell populations, hyperplastic nodules, to the acute cytotoxic effects of some hepatocarcinogens. Cancer Res.36: 3897.
15.
FirmingerHI (1955). Histopathology of carcinogenesis and tumors of the liver in rats. J. Natl. Cancer Inst.15: 1427–1442.
16.
FurukawaKMaeuraYFurukawaNTWilliamsGM (1984). Induction by butylated hydroxy-toluene of rat liver gamma-glutamyl transpeptidase activity in comparison to expression in carcinogen-induced altered lesions. Chem. Biol. Interact.48: 43–58.
17.
FurukawaKNumotaSFuruyaKFurukawaNWilliamsGM (1985). Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital. Cancer Res.5011–5019.
18.
FuruyaKWilliamsGM (1984). Neoplastic conversion in rat liver by the antihistamine methapyrilene demonstrated by a sequential syncarcinogenic effect with N-2-fluorenylacetamide. Toxicol. Appl. Pharmacol.74: 63–69.
19.
FuruyaKMaeuraYWilliamsGM (1984). Abnormalities in liver iron accumulation during N-2-fluorenylacetamide hepatocarcinogenesis that are dependent or independent of continued carcinogen action. Toxicol. Pathol.12: 136–142.
20.
GodlewskiCEBoydJNShermanWKAndersonJLStoewsandGS (1985). Hepatic glutathione S-transferase activity and aflatoxin Bl-induced enzyme altered foci in rats fed fractions of brussels sprouts. Cancer Lett.28: 51–157.
21.
GossnerVWFriedrich-FreskaH (1964). Histochemische untersuchungen iiber die glucose-6-phosphatase in der rattenieber wahrend der Kanzeristerung durch nitrosamine. Z. Naturforsch.19b: 862–863.
22.
HaradaMOkabeKShibataKMasudaHMiyataKEnomotoM (1976). Histochemical demonstration of increased activity of gamma-glutamyl transpeptidase in rat liver during hepatocarcinogenesis. Acta Histochem.9: 168–179.
23.
HerrenSLPereiraMABrittALKhouryMK (1982). Initiation/promotion assay for chemical carcinogens in rat liver. Toxicol. Lett.12: 143–150.
24.
HirotaNWilliamsGM (1979). Persistence and growth of rat liver neoplastic nodules following cessation of carcinogen exposure. J. Natl. Cancer Inst.63: 1257–1265.
25.
HirotaNWilliamsGM (1979). The sensitivity and heterogeneity of histochemical markers for altered foci involved in liver carcinogenesis. Am. J. Pathol.95: 317–324.
26.
HirotaNWilliamsGM (1982). Ultrastructural abnormalities in carcinogen-induced hepatocellular altered foci identified by resistance to iron accumulation. Cancer Res.42: 2298–2309.
27.
HirotaNHamazakiMWilliamsGM (1982). Resistance to iron accumulation and presence of hepatitis B surface antigen in preneoplastic and neoplastic lesions in human hemochromatotic livers. Hepatogastroenterology29: 49–51.
28.
InaokaY (1967). Significance of the so-called oval cell proliferation during azo-dye hepatocarcinogenesis. Gann58: 355–366.
29.
IshikawaTTakayamaSKitagawaTKawachiTSugimuraT (1979). Induction of enzyme-altered islands in rat liver by tryptophan pyrolysis products. J. Cancer Res. Clin. Oncol.95: 221–224.
30.
JonesDEJr.EvcesSLindahlR (1984). Expression of tumor-associated aldehyde dehydrogenase during rat hepatocarcinogenesis using the resistant hepatocyte model. Carcinogenesis5: 1679–1687.
31.
JudahDJLeggRFNealGE (1977). Development of resistance to cytotoxicity during aflatoxin carcinogenesis. Nature265: 43–345.
32.
KalengayiMMRRochiGDesmetVJ (1975). Histochemistry of gamma-glutamyl transpeptidase in rat liver during aflatoxin B1 -induced carcinogenesis. J. Natl. Cancer Inst.55: 579–588.
33.
KatayamaSOhmoriTMaeuraYCrociTWilliamsGM (1984). Early stages of N-2-fluroenylacetamide-induced hepatocarcinogenesis in male and female rats and effects of gonadectomy on liver neoplastic conversion and neoplastic development. J. Natl. Cancer Inst.73: 141–149.
34.
KitagawaT (1971). Histochemical analysis of hyperplastic lesions and hepatomas of the liver of rats fed 2-fluorenylacetamide. Gann62: 207–216.
35.
KitagawaTSuganoH (1978). Enhancing effect of phenobarbital on the development of enzyme-altered islands and hepatocellular carcinomas initiated by 3î-methyl-4-(dimethylamino) azobenzene or diethylnitrosamine. Gann69: 679–687.
36.
KitagawaTImaiFSatoK (1980). Re-elevation of gamma-glutamyl transpeptidase activity in periportal hepatocytes of rats with age. Gann71: 362–366.
37.
KitaharaASatohKSatoJ (1983). Properties of the increased glutathione S-transferase A form in rat preneoplastic hepatic lesions induced by chemical carcinogens. Biochem. Biophys. Res. Commun.112: 20–28.
38.
KitaharaASatoaKNishimuraKIshikawaTRuikeKSataKTsudaHItoN (1984). Chances in molecular forms of rat hepatic glutathione S-transferase during chemical hepatocarcinogenesis. Cancer Res.44: 2698–2703.
39.
KohigashiKFukudaYImuraH (1988). Inhibitory effect of tamoxifen on diethylstilbestrol-promoted hepatic tumorigenesis in male rats and its possible mechanism of action. Jpn. J. Cancer Res.79: 1335–1339.
40.
KuhlmannWDKrischanRKunzWGuentherTMOeschF (1981). Focal elevation of liver microsomal epoxide hydrolase in early preneoplastic stages and its behavior in the further course of hepatocarcinogenesis. Biochem. Biophys. Res. Commun.98: 417–423.
41.
KurutaYStudyHTamamoSItoN (1985). Inhibitory potential of acetaminophen and o-, m-, p-aminophenols for development of gamma-glutamyltranspeptidase-positive liver cell foci in rats pretreated with diethylnitrosamine. Cancer Lett.28: 19–25.
42.
LaibRJStockleGBoltHMKunzW (1979). Vinyl chloride and trichloroethylene: Comparison of alkylating effects of metabolites and induction of preneoplastic enzyme deficiencies in rat liver. J. Cancer Res. Clin. Oncol.94: 139–147.
43.
LeonardTBDentJGGrachenMELyghtOPoppJA (1982). Comparison of hepatic carcinogen initiation-promotion systems. Carcinogenesis3: 851–856.
MaeuraYWilliamsGM (1984). Enhancing effect of butylated hydroxytoluene on the development of liver altered foci and neoplasms induced by N-2-fluorenylacetamide in rats. Fd. Chem. Toxicol.22: 191–198.
46.
MaeuraYWeisburgerJHWilliamsGM (1984). Dose-dependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene. Cancer Res.44: 1604–1610.
47.
MaruyamaHTanakaTWilliamsGM (1988). Activity of the anorectic agent l,3-bis[2-cyano-5-(trifluoromethyl)-phenyl]triazene in in vitro and in vivo liver promoting assays. Cancer Lett.40: 13–21.
48.
MazueGRemandetBGouyDBertheJRoncucciRWilliamsGM (1982). Limited in vivo bioassays on some benzodiazepine tranquilizers diazepam, clorazepate, oxazepam and lorazepam. Arch. Int. Pharmacol. Ther.257: 59–65.
49.
MilksMMWiltSRAliIPereiraMACouriD (1982). Dibromoethane effects on the induction of gamma-glutamyl transpeptidase positive foci in rat liver. Arch. Toxicol.51: 27–35.
50.
MilmanHAStoryDLRiccioESSivakATuAWilliamsGMTongCTysonCA (1988). Rat liver foci and in vitro assays to detect initiating and promoting effects of chlorinated ethanes and ethylenes. In: Living in a Chemical World. MaltoniCSelikoffIJ (eds). Ann. NY Acad. Sci. pp. 521–530.
51.
MitakaTTsukadaH (1987). Sexual difference in the histochemical characteristics of “altered cell foci” in the liver of aged Fischer 344 rats. Jpn. J. Cancer Res.78: 785–790.
52.
MooreMRDrinkwaterNRMillerECMillerJAPitotHC (1981). Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine. Cancer Res.41: 1585–1593.
53.
MoriHTanakaTNishikawaATakahashiMWilliamsGM (1981). Enhancing effect of barbital on N-2-fluorenylacetamide-induced rat liver lesions. Gann72: 798–801.
54.
MoriHTanakaTSugieSTakahashiMWilliamsGM (1982). DNA content of liver cell nuclei of N-2-fluorenylacetamide-induced altered foci and neoplasms in rats and human hyperplastic foci. J. Natl. Cancer Inst.69: 1277–1282.
55.
MoriHMuBWilliamsGM (1982). Isolation and enrichment of cells resistant to iron accumulation from carcinogen-induced rat liver altered foci. Exp. Mol. Pathol.37: 101–110.
56.
MoriHFuruyaKWilliamsGM (1983). Enhanced survival and absence of progressive growth of transplanted rat liver altered eosinophilic foci and neoplastic nodules in phenobarbital-treated rats. J. Natl. Cancer Inst.71: 849–854.
57.
MoriHKuniyasuTSugieSShimaHTakahashiM (1985). Syncarcinogenic effects of methyl methanesulfonate with methylazoxymethanol acetate in rat small intestine and liver. Carcinogenesis6: 1529–1531.
58.
NatriaTWatanabeRKitagawaT (1980). Mechanisms of inhibition by simultaneously administered phenobarbital of 3î-methyl-4-(dimethyl-amino) azobenzene-induced hepatocarcinogenesis in the rat. Gann71: 755–758.
59.
NewbernePMWoganGN (1968). Sequential morphologic changes in aflatoxin B carcinogenesis in the rat. Cancer Res.28: 770–781.
60.
NumotoSFurukawaKFuruyaKWilliamsGM (1984). Effects of the hepatocarcinogenic per-oxisome-proliferating hypolipidemic agents clofibrate and nafenopin on the rat liver cell membrane enzymes gamma-glutamyltranspeptidase and alkaline phosphatase and on the early stages of liver carcinogenesis. Carcinogenesis5: 1603–1611.
61.
OgawaKOnoeTTakeuchiM (1981). Spontaneous occurrence of gamma-glutamyl transpeptidase-positive hepatocytic foci in 105-week-old Wistar and 72-week-old Fischer 344 male rats. J. Natl. Cancer Inst.67: 407–412.
62.
OkitaKNodaKFukumotoYTakematoT (1976). Cytochrome P-450 in hyperplastic liver nodules during hepatocarcinogenesis with N-2-fluoren-ylacetamide in rats. Gann67: 899–902.
63.
PerainoCStaffeldtEFLudemanVA (1981). Early appearance of histochemically altered hepatocyte foci and liver tumors in female rats treated with carcinogens one day after birth. Carcinogenesis2: 463–465.
64.
PerainoCStaffeldtEFCarnesBALudemanVABlomquistJAVesselinovitchSD (1984). Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or benzo(a)pyrene within one day after birth. Cancer Res.44: 3340–3347.
65.
PereiraMA (1982). Rat liver foci bioassay. J. Am. Coll. Toxicol.1: 101–117.
66.
PereiraMAHerrenSLBrittALKhouryMM (1982). Sex difference in enhancement of GGTase-positive foci by hexachlorobenzene and lindane in rat liver. Cancer Lett.15: 95–101.
67.
PereiraMAHerrenSLBrittALKhouryMM (1982). Promotion by polychlorinated biphenyls of enzyme-altered foci in rat liver. Cancer Lett.15: 185–190.
68.
PereraMIShinozukaH (1984). Accelerated regression of carcinogen-induced preneoplastic hepatocyte foci by peroxisome proliferators, BR931, 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio (N-B-hydroxyethyl)acetamide, and di-(2-ethylhex-yl)phthalate. Carcinogenesis5: 1193–1198.
69.
PitotHCSiricaAE (1980). The stages of initiation and promotion in hepatocarcinogenesis. Biochim. Biophys. Acta604: 191–215.
70.
PitotHCBarsnessLGoldsworthyTKitagawaT (1978). Biochemical characterization of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine. Nature271: 456–458.
71.
PitotHCGoldsworthyTCampbellHAPolandA (1980). Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Cancer Res.40: 3616–3620.
72.
PoppJAScortichiniBHGarveyLK (1985). Quantitative evaluation of hepatic foci of cellular alteration occurring spontaneously in Fischer-344 rats. Fund. Appl. Toxicol.5: 314–319.
73.
PughTDGoldfarbS (1978). Quantitative histochemical and autoradiographic studies of hepatocarcinogenesis in rats fed 2-acetylaminofluorene followed by phenobarbital. Cancer Res.38: 4450–4457.
74.
RabesHMSzymkowiakR (1979). Cell kinetics of hepatocytes during the preneoplastic period of diethylnitrosamine-induced liver carcinogenesis. Cancer Res.39: 1298–1304.
75.
RabesHMScholzePJantschB (1972). Growth kinetics of diethylnitrosamine-induced, enzyme-deficient “preneoplastic” liver cell populations in vivo and in vitro. Cancer Res.32: 2577–2586.
76.
RabesHMBucherTHartmannALinkeIDunnwoldM (1982). Clonal growth of carcinogen-induced enzyme-deficient preneoplastic cell populations in mouse liver. Cancer Res.42: 3220–3227.
77.
ReillyCAJr.PerainoCHaugenDAMahlumDDSpringerDL (1985). Promotion of preneoplastic changes in liver by coal-derived organic mixtures applied to skin. Cancer Lett.28: 121–125.
78.
RemandetBGouyDBertheJMazueGWilliamsGM (1984). Lack of initiating or promoting activity of six benzodiazepine tranquilizers in rat liver limited bioassays monitored by histopathology and assay of liver and plasma enzymes. Fund. Appl. Toxicol.4: 152–163.
79.
ReuberMD (1965). Development of preneoplastic and neoplastic lesions of the liver in male rats given 0.025 percent N-2-fluorenyldiacetamide. J. Natl. Cancer Inst.34: 697–724.
80.
SchererEHoffmannMEmmelotPFriedrich-FreskaM (1972). Quantitative study of foci of altered liver cells induced in the rat by a single dose of diethylnitrosamine and partial hepatectomy. J. Natl. Cancer Inst.49: 93–106.
81.
Schulte-HermannROhdeGSchupplerJTimmermann-TrosienerI (1981). Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin. Cancer Res.41: 2556–2562.
82.
SchwarzMBannaschPKunzW (1983). The effect of pre- and post-treatment with phenobarbital on the extent of gamma-glutamyl transpeptidase positive foci induced in rat liver by N-nitrosomorpholine. Cancer Lett.21: 17–21.
83.
SellSRuoslahtiE (1982). Expression of fibronectin and laminin in the rat liver after partial hepatectomy, during carcinogenesis, and in transplantable hepatocellular carcinomas. J. Natl. Cancer Inst.69: 1105–1114.
84.
ShinozukaHLombardiBSellSIammarinoRM (1978). Early histological and functional alterations of ethionine liver carcinogenesis in rats fed a choline-deficient diet. Cancer Res.38: 1092–1098.
85.
ShinozukaHLombardiBAbanobiSE (1982). A comparative study of the efficacy of four barbiturates as promoters of the development of gammaglutamyltranspeptidase-positive foci in the liver of carcinogen treated rats. Carcinogenesis3: 1017–1020.
86.
ShiraiTHosodaKHiroseMItoN (1985). Promoting effects of phenobarbital and 3'-methyl-4-dimethylaminoazobenzene on the appearance of gamma-glutamyltranspeptidase positive foci in rat liver pretreated with varying doses of diethylnitrosamine. Cancer Lett.28: 127–133.
87.
StaubliWBentleyPBieriFFrohlichEWaechterF (1984). Inhibitory effect of nafenopin upon the development of diethylnitrosamine-induced enzyme-altered foci within the rat liver. Carcinogenesis5: 41–46.
88.
StenbackFMoriHFuruyaKWilliamsGM (1986). Pathogenesis of dimethylnitrosamine-induced hepatocellular cancer in hamster liver and lack of enhancement by phenobarbital. J. Natl. Cancer Inst.76: 327–333.
89.
StewartHLWilliamsGMKeysserCHLombardLSMontaliRJ (1980). Histologic typing of liver tumors of the rat. Institute of Laboratory Animal Resources, National Research Council, National Academy of Sciences, Washington, D.C. J. Natl. Cancer Inst.64: 177–206.
90.
TanakaTMoriHWilliamsGM (1987). Enhancement of dimethylnitrosamine-initiated hepatocarcinogenesis in hamsters by subsequent administration of carbon tetrachloride but not phenobarbital or p, pî-dichlorodiphenyltrichloroethane. Carcinogenesis8: 1171–1178.
91.
TatematsuMShiraiTTsudaHMiyataYShi-NoharaYItoN (1977). Rapid production of hyperplastic liver nodules in rats treated with carcinogenic chemicals: A new approach for an in vivo short-term screening test for hepatocarcinogens. Gann68: 499–507.
92.
TatematsuMHasegawaRImaidaKTsudaHItoN (1983). Survey of various chemicals for initiating and promoting activities in a short-term in vivo system based on generation of hyperplastic liver nodules in rats. Carcinogenesis4: 381–386.
93.
TimmeAH (1978). Hyperplastic foci in precancerous rat liver: Light microscopic and electron microscopic study. J. Natl. Cancer Inst.61: 407–408.
94.
TsudaHLeeGFarberE (1980). Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens. Cancer Res.40: 1157–1164.
95.
TsudaHSakataTMasuiTImaidaKItoN (1984). Modifying effects of butylated hydroxyanisole, ethoxyquin and acetaminophen on induction of neoplastic lesions in rat liver and kidney initiated by N-ethyl-N-hydroxyethylnitrosamine. Carcinogenesis5: 525–531.
96.
WardJM (1981). Morphology of foci of altered hepatocytes and naturally-occurring hepatocellular tumors in F344 rats. Virchows Arch. A. Pathol. Anat.390: 339–345.
97.
WatanabeKWilliamsGM (1978). Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: Evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions. J. Natl. Cancer Inst.61: 1311–1314.
98.
WattenbergLW (1985). Chemoprevention of cancer. Cancer Res.45: 1–8.
99.
WeisburgerJHWilliamsGM (1981). Carcinogen testing: Current problems and new approaches. Science214: 401–407.
100.
WilliamsGM (1976). Functional markers and growth behavior of preneoplastic hepatocytes. Cancer Res.36: 2540–2543.
101.
WilliamsGM (1980). The pathogenesis of rat liver cancer caused by chemical carcinogens. Biochem. Biophys. Acta605: 167–189.
102.
WilliamsGM (1981). Liver carcinogenesis: The role for some chemicals of an epigenetic mechanism of liver-tumor promotion involving modification of the cell membrane. Fd. Cosmet. Toxicol.19: 577–583.
103.
WilliamsGM (1982). Phenotypic properties of preneoplastic rat liver lesions and applications to detection of carcinogens and tumor promoters. Toxicol. Pathol.10: 3–10.
104.
WilliamsGM (1984). Modulation of chemical carcinogenesis by xenobiotics. Fund. Appl. Toxicol.4: 325–344.
105.
WilliamsGM (1987). The significance of preneoplastic liver lesions in experimental animals. In: Advances in Veterinary Science and Comparative Medicine, Vol. 31. RicoA (ed). Academic Press, NY, pp. 21–44.
106.
WilliamsGMFuruyaK (1984). Distinction between liver neoplasm promoting and syncarcinogenic effects demonstrated by exposure to phenobarbital or diethylnitrosamine either before or after N-2-fluorenylacetamide. Carcinogenesis5: 171–174.
107.
WilliamsGMNumotoS (1984). Promotion of mouse liver neoplasms by the organochlorine pesticides chlordane and heptachlor in comparison to dichlorodiphenyltrichloroethane. Carcinogenesis5: 1689–1696.
108.
WilliamsGMWatanabeK (1978). Quantitative kinetics of development of N-2-fluorenylacetamide-induced, altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion or persistence following removal of carcinogen. J. Natl. Cancer Inst.61: 113–121.
109.
WilliamsGMWeisburgerJH (1986). In: Toxicology, The Basic Sciences of Poison, 3rd ed.KlaassenCAmdurMDoullJ (eds). Macmillan Pub. Co., NY, pp. 99–173.
110.
WilliamsGMYamamotoRS (1972). Absence of stainable iron from preneoplastic and neoplastic lesions in rat liver with 8-hydroxyquinoline-induced siderosis. J. Natl. Cancer Inst.49: 685–692.
111.
WilliamsGMKlaiberMParkerSEFarberE (1976). Nature of early appearing, carcinogen-induced liver lesions to iron accumulation. J. Natl. Cancer Inst.57: 157–165.
112.
WilliamsGMKatayamaSOhmoriT (1981). Enhancement of hepatocarcinogenesis by sequential administration of chemicals: Summation versus promotion effects. Carcinogenesis2: 1111–1117.
113.
WilliamsGMTanakaTMaeuraY (1986). Dose-related inhibition of aflatoxin B1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene. Carcinogenesis7: 1043–1050.
114.
YagerJDCampbellHALongneckerDSRoebuckBDBenoitMC (1984). Enhancement of hepatocarcinogenesis in female rat by ethinyl estradiol and mestranol but not estradiol. Cancer Res.44: 3862–3869.
